Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Scope of the Report:
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
The worldwide market for Gastrointestinal is expected to grow at a CAGR of roughly 0.9% over the next five years, will reach 35300 million US$ in 2024, from 33600 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Gastrointestinal in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Af ...
Table of Contents
1 Market Overview
1.1 Gastrointestinal Introduction
1.2 Market Analysis by Type
1.2.1 Prescription Gastrointestinal Drug
1.2.2 OTC Gastrointestinal Drug
1.3 Market Analysis by Applications
1.3.1 Chronic Gastritis
1.3.2 Functional Dyspepsia
1.3.3 Peptic Ulcer
1.3.4 Acute Gastroenteritis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
184.108.40.206 United States Market States and Outlook (2014-2024)
220.127.116.11 Canada Market States and Outlook (2014-2024)
18.104.22.168 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
22.214.171.124 Germany Market States and Outlook (2014-2024)
126.96.36.199 France Market States and Outlook (2014-2024)
188.8.131.52 UK Market States and Outlook (2014-2024)
184.108.40.206 Russia Market States and Outlook (2014-20 ...